Icon (ICLR) Stock: Buy, Sell, or Hold?
ICLR - Icon Plc
$169.31
3.62 (2.18%)
▲
5d:
+3.5%
30d:
+1.28%
90d:
+12.93%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 28, 2026
Get Alerted When ICLR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ICLR trades at premium valuation expecting 6.6% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: ICLR trades at premium valuation expecting 6.6% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$206.48
Based on 8.1% avg growth
INTRINSIC VALUE TODAY
$128.21
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ICLR is currently trading at $169.31, which is considered slightly high relative to its 30-day fair value range of $161.14 to $170.44. From a valuation perspective, the stock is trading at a premium (Forward PE: 14.3) compared to its historical average (11.8). At these levels, the market is pricing in 6.6% annual earnings growth.
Technical Outlook: Technically, ICLR is in a strong uptrend. Immediate support is located at $156.70, while resistance sits at $175.63.
Market Sentiment: The stock scores a mixed 51/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ICLR is in a strong uptrend. Immediate support is located at $156.70, while resistance sits at $175.63.
Market Sentiment: The stock scores a mixed 51/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$161.14 -
$170.44
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.8%
Protect Your Profits
Holding ICLR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (51/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($185.56)
- BULLISH: Expecting earnings turnaround to 6.6% growth with 1.2% revenue growth
- NEUTRAL: Bottoming setup forming (51/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$161.14 -
$170.44
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$156.70
Resistance Level
$175.63
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.26
Wall Street Target
$185.56
(+9.6%)
Revenue Growth (YoY)
1.2%
Earnings Growth (YoY)
-63.3%
Profit Margin
0.3%
Valuation Premium vs History
+6.6% premium
PE vs Historical
14.3 vs 11.8
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.6%
(market-implied from PE analysis)
1-Year Target
$180.48
(+7%)
2-Year Target
$192.40
(+14%)
3-Year Target
$205.09
(+21%)
3-Yr Target (if PE normalizes)
(PE: 14→12)
PE COMPRESSION
$169.74
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 12.2%)
$338.11
(+100%)
Base:
(SPY PE: 14.3, Growth: 12.2%)
$239.00
(+41%)
Bear:
(PE: 11.8, Growth: 12.2%)
$197.81
(+17%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (14x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Forward PE: 14.35 | Forward EPS (Implied): $11.80
Bull Case
$204.44
(+21%)
Analyst growth 15.0%, PE expands to 15.1
Base Case
$169.31
(0%)
Market implied 0.0%, PE stable at 14.4
Bear Case
$129.52
(-24%)
Severe decline -15.0%, PE contracts to 12.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 12, 2026 2:30 PM ET
Data refreshes hourly during market hours. Next update: 3:30 PM
Data refreshes hourly during market hours. Next update: 3:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICLR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$638 | 51 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$229 | 49 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$194 | 49 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$338 | 47 HOLD |
Advanced ICLR Option Strategies
Professional options setups generated by AI based on today's ICLR price and gamma walls.
